40
Participants
Start Date
April 29, 2025
Primary Completion Date
November 1, 2026
Study Completion Date
November 1, 2026
Von Willebrand Factor Concentrates
Used according to local labeling or local treatment guidelines.
Von Willebrand Factor Concentrates and Factor VIII Concentrates
Used according to local labeling or local treatment guidelines.
Factor VIII Concentrates
Used according to local labeling or local treatment guidelines.
Recombinant Activated Factor VII
Used according to local labeling or local treatment guidelines.
Activated Prothrombin Complex Concentrate
Used according to local labeling or local treatment guidelines.
RECRUITING
UZ Leuven Gasthuisberg, Leuven
RECRUITING
Hospital Universitario la Paz, Madrid
RECRUITING
Hospital Universtiario Virgen del Rocio, Seville
RECRUITING
Gerinnungszentrum Rhein-Ruhr;Gerinnungsambulanz, Duisburg
RECRUITING
AOU Careggi, Florence
RECRUITING
Universitätsklinikum Bonn, Bonn
RECRUITING
Hopital Claude Huriez - CHU Lille, Lille
RECRUITING
Hämophiliezentrum Med. Klinik III/Institut für Transfusionsmedizin, Frankfurt/M.
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Groupe Hospitalier Necker Enfants Malades, Paris
RECRUITING
UC Davis, Sacramento
RECRUITING
The Hospital for Sick Children, Toronto
RECRUITING
McGill University Health Center, Montreal
RECRUITING
IPS SURA Industriales Medellín, Medellín
RECRUITING
Universita' Degli Studi La Sapienza-Ist.Di Ematologia, Rome
RECRUITING
Kurume University Hospital, Fukuoka
RECRUITING
Tokyo Medical University Hospital, Tokyo
RECRUITING
Erasmus MC, Rotterdam
RECRUITING
Instytut Hematologii i Transfuzjologii, Warsaw
RECRUITING
Sahlgrenska Universitetssjukhuset, Gothenburg
RECRUITING
St Thomas' Hospital, London
RECRUITING
Great Ormond Street Hospital, London
RECRUITING
Manchester Royal Infirmary, Manchester
Hoffmann-La Roche
INDUSTRY